Just last week, the Philippine government entered a tripartite deal with a private firm headed by ports businessman Enrique Razon and US-based vaccine producer, Moderna, for the procurement of 20 million doses.
Of that number, 13 million has been assured to the government, while the private sector will be giving 7 million doses for frontliners.
Currently, Moderna is pursuing an emergency use authorization in order to use the vaccine in the country.
According to National Task Force chief and vaccine czar Carlito Galvez Jr., these doses would go a long way in providing a “steady supply of vaccines” for the whole year. Meanwhile, Razon said that his company “has formally committed to manage and fund the entire international logistical efforts for the Moderna order.”
So far, companies that have gained emergency use authorization for their vaccines in the Philippines are the Chinese vaccine maker Sinovac, British drugmaker AstraZeneca, US’ Pfizer-BioNTech and the Russian manufacturer Gamaleya.
According to Galvez, the government aims to inoculate 50 to 70 million Filipinos within the year, by targeting one million vaccinations per week in April, two million vaccinations per week in May and three to five million vaccinations per week in June.